Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Account Payables: 2010-2024

Historic Change in Account Payables for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -$733,916.

  • China Pharma Holdings' Change in Account Payables fell 77.67% to $54,437 in Q3 2025 from the same period last year, while for Sep 2025 it was $202,297, marking a year-over-year increase of 143.02%. This contributed to the annual value of -$733,916 for FY2024, which is 335.20% down from last year.
  • According to the latest figures from FY2024, China Pharma Holdings' Change in Account Payables is -$733,916, which was down 335.20% from $312,045 recorded in FY2023.
  • Over the past 5 years, China Pharma Holdings' Change in Account Payables peaked at $312,045 during FY2023, and registered a low of -$733,916 during FY2024.
  • Over the past 3 years, China Pharma Holdings' median Change in Account Payables value was -$187,734 (recorded in 2022), while the average stood at -$203,202.
  • Per our database at Business Quant, China Pharma Holdings' Change in Account Payables skyrocketed by 266.22% in 2023 and then slumped by 335.20% in 2024.
  • Yearly analysis of 5 years shows China Pharma Holdings' Change in Account Payables stood at -$214,015 in 2020, then tumbled by 55.49% to -$332,779 in 2021, then soared by 43.59% to -$187,734 in 2022, then surged by 266.22% to $312,045 in 2023, then crashed by 335.20% to -$733,916 in 2024.